Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACEUTICAL TECHNOLOGY II | PHA3214157 | Spring Semester | 3+0 | 3 | 5 |
| Course Program | Çarşamba 09:00-09:45 Çarşamba 10:00-10:45 Çarşamba 11:00-11:45 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Prof.Dr. Fatma Julide AKBUĞA |
| Name of Lecturer(s) | Prof.Dr. Fatma Julide AKBUĞA |
| Assistant(s) | |
| Aim | To inform the student about rheology, the properties of two phase systems, semisolid dosage forms and their functions and quality controls. |
| Course Content | This course contains; Rheology,Colloids,Interfacial properties,Suspensions,Suspensions,Emulsions,Emulsions,Semi solid dosage forms,Semi solid dosage forms,Permeability from the skin and transdermal systems,Permeability from the skin and transdermal systems,Suppositories,Aerosols,Basic pharmacokinetic. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. will be assessed the rheological and interfacial properties | 10, 16, 9 | A |
| 1.1. define types of rheological behaviour | 16, 9 | A |
| 1.2. evaluate the measurement of rheological properties | 16, 9 | A |
| 1.3. defines adsorption on liquid and solid interface, solid-gase interface and solid-liquid interface. | 16, 9 | A |
| 1.4. comment the effect on drug efficacy of adsorption isotherms and adsorbent matters. | 16, 9 | A |
| 1.5. classify the surface-active ingredients. | 16, 9 | A |
| 2. will be designed suspension and emulsion formulations | 16, 9 | A |
| 2.1. define suspension and emulsion formulations | 16, 9 | A |
| 2.2. list the compounds of suspension and emulsion formulations | 16, 9 | A |
| 2.3. debate the controls in suspensions and emulsions | 16, 9 | A |
| 2.4. determine the methods of suspensions and emulsions preparation | 16, 9 | A |
| 2.5. evaluate the stability of suspension and emulsion | 16, 9 | A |
| 3. will be designed aerosol systems | 16, 9 | A |
| 3.1. evaluate the respiratory drug delivery | 16, 9 | A |
| 3.2. debate the aerosol systems and it’s usage | 16, 9 | A |
| 3.3. list the compounds of aerosol systems | 16, 9 | A |
| 3.4. evaluate the quality control tests in aerosols | 16, 9 | A |
| 4. will be designed semi-solid dosage forms | 19, 9 | A |
| 4.1. classify definition of semi-solid dosage forms and it’s formulation types | 16, 9 | A |
| 4.2. evaluate permeability from the skin and semi-solid preparations applied to the skin | 16, 9 | A |
| 4.3. classify the ingredient of ointment, path, gel, cream, lotion and cera formulations | 16, 9 | A |
| 4.4. evaluate the forms of formulated preparations | 16, 9 | A |
| 4.5. define the suppository and ovule formulations. | 16, 9 | A |
| 4.6. debate the methods of formulated preparations | 16, 9 | A |
| Teaching Methods: | 10: Discussion Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Rheology | 1,2,3 |
| 2 | Colloids | 1,2,3 |
| 3 | Interfacial properties | 1,2,3 |
| 4 | Suspensions | 1,2,3 |
| 5 | Suspensions | 1,2,3 |
| 6 | Emulsions | 1,2,3 |
| 7 | Emulsions | 1,2,3 |
| 8 | Semi solid dosage forms | 1,2,3 |
| 9 | Semi solid dosage forms | 1,2,3 |
| 10 | Permeability from the skin and transdermal systems | 1,2,3 |
| 11 | Permeability from the skin and transdermal systems | 1,2,3 |
| 12 | Suppositories | 1,2,3 |
| 13 | Aerosols | 1,2,3 |
| 14 | Basic pharmacokinetic | 1,2,3 |
| Resources |
| 1-Lecture notes, Powerpoint presentations, Relevant web pages will be given to students. 2-Acartürk F, Ağabeyoğlu İ, Çelebi D, Değim T, Değim Z, Doğanay T, Taka S, Tırnaksız F. Modern Farmasötik Teknoloji. Türk Eczacılar Birliği Yayını. 2.baskı. Ankara.2008 3-Zırh Gürsoy A (ed.). Farmasötik Teknoloji –Temel Konular ve Dozaj Şekilleri- Kontrollü Salım Sistemleri Derneği Yayını. 2.baskı. İstanbul. 2011 |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 3 | 42 | |||
| Guided Problem Solving | 0 | 0 | 0 | |||
| Resolution of Homework Problems and Submission as a Report | 2 | 5 | 10 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 1 | 30 | 30 | |||
| General Exam | 1 | 60 | 60 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 142 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(142/30) | 5 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACEUTICAL TECHNOLOGY II | PHA3214157 | Spring Semester | 3+0 | 3 | 5 |
| Course Program | Çarşamba 09:00-09:45 Çarşamba 10:00-10:45 Çarşamba 11:00-11:45 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Prof.Dr. Fatma Julide AKBUĞA |
| Name of Lecturer(s) | Prof.Dr. Fatma Julide AKBUĞA |
| Assistant(s) | |
| Aim | To inform the student about rheology, the properties of two phase systems, semisolid dosage forms and their functions and quality controls. |
| Course Content | This course contains; Rheology,Colloids,Interfacial properties,Suspensions,Suspensions,Emulsions,Emulsions,Semi solid dosage forms,Semi solid dosage forms,Permeability from the skin and transdermal systems,Permeability from the skin and transdermal systems,Suppositories,Aerosols,Basic pharmacokinetic. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. will be assessed the rheological and interfacial properties | 10, 16, 9 | A |
| 1.1. define types of rheological behaviour | 16, 9 | A |
| 1.2. evaluate the measurement of rheological properties | 16, 9 | A |
| 1.3. defines adsorption on liquid and solid interface, solid-gase interface and solid-liquid interface. | 16, 9 | A |
| 1.4. comment the effect on drug efficacy of adsorption isotherms and adsorbent matters. | 16, 9 | A |
| 1.5. classify the surface-active ingredients. | 16, 9 | A |
| 2. will be designed suspension and emulsion formulations | 16, 9 | A |
| 2.1. define suspension and emulsion formulations | 16, 9 | A |
| 2.2. list the compounds of suspension and emulsion formulations | 16, 9 | A |
| 2.3. debate the controls in suspensions and emulsions | 16, 9 | A |
| 2.4. determine the methods of suspensions and emulsions preparation | 16, 9 | A |
| 2.5. evaluate the stability of suspension and emulsion | 16, 9 | A |
| 3. will be designed aerosol systems | 16, 9 | A |
| 3.1. evaluate the respiratory drug delivery | 16, 9 | A |
| 3.2. debate the aerosol systems and it’s usage | 16, 9 | A |
| 3.3. list the compounds of aerosol systems | 16, 9 | A |
| 3.4. evaluate the quality control tests in aerosols | 16, 9 | A |
| 4. will be designed semi-solid dosage forms | 19, 9 | A |
| 4.1. classify definition of semi-solid dosage forms and it’s formulation types | 16, 9 | A |
| 4.2. evaluate permeability from the skin and semi-solid preparations applied to the skin | 16, 9 | A |
| 4.3. classify the ingredient of ointment, path, gel, cream, lotion and cera formulations | 16, 9 | A |
| 4.4. evaluate the forms of formulated preparations | 16, 9 | A |
| 4.5. define the suppository and ovule formulations. | 16, 9 | A |
| 4.6. debate the methods of formulated preparations | 16, 9 | A |
| Teaching Methods: | 10: Discussion Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Rheology | 1,2,3 |
| 2 | Colloids | 1,2,3 |
| 3 | Interfacial properties | 1,2,3 |
| 4 | Suspensions | 1,2,3 |
| 5 | Suspensions | 1,2,3 |
| 6 | Emulsions | 1,2,3 |
| 7 | Emulsions | 1,2,3 |
| 8 | Semi solid dosage forms | 1,2,3 |
| 9 | Semi solid dosage forms | 1,2,3 |
| 10 | Permeability from the skin and transdermal systems | 1,2,3 |
| 11 | Permeability from the skin and transdermal systems | 1,2,3 |
| 12 | Suppositories | 1,2,3 |
| 13 | Aerosols | 1,2,3 |
| 14 | Basic pharmacokinetic | 1,2,3 |
| Resources |
| 1-Lecture notes, Powerpoint presentations, Relevant web pages will be given to students. 2-Acartürk F, Ağabeyoğlu İ, Çelebi D, Değim T, Değim Z, Doğanay T, Taka S, Tırnaksız F. Modern Farmasötik Teknoloji. Türk Eczacılar Birliği Yayını. 2.baskı. Ankara.2008 3-Zırh Gürsoy A (ed.). Farmasötik Teknoloji –Temel Konular ve Dozaj Şekilleri- Kontrollü Salım Sistemleri Derneği Yayını. 2.baskı. İstanbul. 2011 |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |